Drugs / Nanocalcium Hydroxide
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06196515 | Aug 2024 → Sep 2025 overdue | dental pulp disorder | British University In Egypt | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07571837 | Feb 2026 → Jan 2027 expected | periapical periodontitis | Al-Azhar University | Recruiting | No outcome recorded |
| — | NCT07057336 | May → Dec 2024 | chronic apical periodontitis | Cukurova University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nano-calcium hydroxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07571837 ↗ |
| Known as | NCH | “Nanocalcium Hydroxide (NCH)” NCT07057336 ↗ |
| Route | Other | “Nanocalcium hydroxide (NCH) paste was placed into the canal using a Lentulo spiral” NCT07057336 ↗ |